Trial Profile
Double-blind, double-dummy, randomized, placebo-controlled, phase IIa study on the efficacy and tolerability of a 14-day treatment with budesonide effervescent tablets vs. viscous budesonide suspension vs. placebo in patients with eosinophilic esophagitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Sep 2015
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Eosinophilic oesophagitis
- Focus Therapeutic Use
- 19 Aug 2014 New trial record